SE9704644D0 - New use - Google Patents

New use

Info

Publication number
SE9704644D0
SE9704644D0 SE9704644A SE9704644A SE9704644D0 SE 9704644 D0 SE9704644 D0 SE 9704644D0 SE 9704644 A SE9704644 A SE 9704644A SE 9704644 A SE9704644 A SE 9704644A SE 9704644 D0 SE9704644 D0 SE 9704644D0
Authority
SE
Sweden
Prior art keywords
new use
formoterol
solvate
salt
medicament
Prior art date
Application number
SE9704644A
Other languages
English (en)
Inventor
Carl Goeran Persson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9704644A priority Critical patent/SE9704644D0/sv
Publication of SE9704644D0 publication Critical patent/SE9704644D0/sv
Priority to PCT/SE1998/002278 priority patent/WO1999030703A1/en
Priority to EP98963701A priority patent/EP1037620A1/en
Priority to JP2000538686A priority patent/JP2002508319A/ja
Priority to AU18971/99A priority patent/AU1897199A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
SE9704644A 1997-12-12 1997-12-12 New use SE9704644D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9704644A SE9704644D0 (sv) 1997-12-12 1997-12-12 New use
PCT/SE1998/002278 WO1999030703A1 (en) 1997-12-12 1998-12-10 Use of formoterol in medicament for inflammation/allergy in upper airways
EP98963701A EP1037620A1 (en) 1997-12-12 1998-12-10 Use of formoterol in medicament for inflammation/allergy in upper airways
JP2000538686A JP2002508319A (ja) 1997-12-12 1998-12-10 上気道における炎症／アレルギーのための薬物でのホルモテロールの使用
AU18971/99A AU1897199A (en) 1997-12-12 1998-12-10 Use of formoterol in medicament for inflammation/allergy in upper airways

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9704644A SE9704644D0 (sv) 1997-12-12 1997-12-12 New use

Publications (1)

Publication Number Publication Date
SE9704644D0 true SE9704644D0 (sv) 1997-12-12

Family

ID=20409370

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9704644A SE9704644D0 (sv) 1997-12-12 1997-12-12 New use

Country Status (5)

Country Link
EP (1) EP1037620A1 (sv)
JP (1) JP2002508319A (sv)
AU (1) AU1897199A (sv)
SE (1) SE9704644D0 (sv)
WO (1) WO1999030703A1 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9903995D0 (sv) * 1999-11-03 1999-11-03 Astra Ab New combination
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
EP1474118A1 (en) * 2002-02-01 2004-11-10 AstraZeneca AB Composition for inhalation
TW200510277A (en) 2003-05-27 2005-03-16 Theravance Inc Crystalline form of β2-adrenergic receptor agonist
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
ES2306595B1 (es) 2007-02-09 2009-09-11 Laboratorios Almirall S.A. Sal de napadisilato de 5-(2-((6-(2,2-difluoro-2-feniletoxi)hexil)amino)-1-hidroxietil)-8-hidroxiquinolin-2(1h)-ona como agonista del receptor adrenergico beta2.
ES2320961B1 (es) 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor adrenergico beta2.
EP2096105A1 (en) 2008-02-28 2009-09-02 Laboratorios Almirall, S.A. Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the b2 adrenergic receptor
EP2228368A1 (en) 2009-03-12 2010-09-15 Almirall, S.A. Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
ITRM20110083U1 (it) 2010-05-13 2011-11-14 De La Cruz Jose Antonio Freire Piastra per la costruzione di carrelli per aeroplani
EP2386555A1 (en) 2010-05-13 2011-11-16 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activities
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2592078A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2592077A1 (en) 2011-11-11 2013-05-15 Almirall, S.A. New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
SG11201504452WA (en) 2012-12-18 2015-07-30 Almirall Sa New cyclohexyl and quinuclidinyl carbamate derivatives having beta2 adrenergic agonist and m3 muscarinic antagonist activity
TWI643853B (zh) 2013-02-27 2018-12-11 阿爾米雷爾有限公司 同時具有β2腎上腺素受體促效劑和M3毒蕈鹼受體拮抗劑活性之2-氨基-1-羥乙基-8-羥基喹啉-2(1H)-酮衍生物之鹽類
TW201517906A (zh) 2013-07-25 2015-05-16 Almirall Sa 含有ｍａｂａ化合物和皮質類固醇之組合
TWI641373B (zh) 2013-07-25 2018-11-21 阿爾米雷爾有限公司 具有蕈毒鹼受體拮抗劑和β２腎上腺素受體促效劑二者之活性的２－胺基－１－羥乙基－８－羥基喹啉－２（１Ｈ）－酮衍生物之鹽
TW201617343A (zh) 2014-09-26 2016-05-16 阿爾米雷爾有限公司 具有β２腎上腺素促效劑及Ｍ３蕈毒拮抗劑活性之新穎雙環衍生物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1088580C (zh) * 1994-12-22 2002-08-07 阿斯特拉公司 气溶胶药物制剂
US5668110A (en) * 1995-06-07 1997-09-16 Affymax Technologies N.V. Peptides and compounds that bind to the IL-5 receptor

Also Published As

Publication number Publication date
JP2002508319A (ja) 2002-03-19
WO1999030703A1 (en) 1999-06-24
EP1037620A1 (en) 2000-09-27
AU1897199A (en) 1999-07-05

Similar Documents

Publication Publication Date Title
SE9704644D0 (sv) New use
ATE339954T1 (de) Kombinationen von formoterol und tiotropium-salz
ATE241970T1 (de) Kombinationen von formoterol und mometasonfuroat
HUP0203590A2 (hu) Gyógyszerkészítmény a csonttömeg csökkenésével járó betegségek kezelésére
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
IL195723A (en) Use of p53 inhibitors for the preparation of medicament
AR023972A1 (es) Composiciones de medicamentos a base de compuestos anticolinergicamente activos y beta-mimeticos
SE9603669D0 (sv) New combination
WO2002100390A3 (en) Improved method of treating the syndrome of coronary heart disease risk factors in humans
DE69930259D1 (de) Zusammensetzungen zur anwendung von entzündungshemmenden, insbesondere antiseptischen und/oder wundheilenden wirkstoffen im oberen atemwegtrakt und/oder ohr
HK1080459A1 (en) Novel pyrimidineamide derivatives and the use thereof
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DK0998287T3 (da) Anvendelse af levobupivacain
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
DK1343472T3 (da) Thixotropisk næsespray
DE60043886D1 (de) Formulierungen mit povidon-iod zur behandlung von wunden
SE9902597D0 (sv) New use
ATE297732T1 (de) Kombinationstherapie zur behandlung von herzinsuffizienz
BR9812531A (pt) Combinação de componentes, preparação farmacêutica, produção desta, e, uso da combinação ou da preparação farmacêutica
HK1073779A1 (en) The use of darifenacin and the salt thereof
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
WO2001028535A3 (en) Pharmaceutical formulations comprising a combination of s-salmeterol and fluticasone propionate
NO995692D0 (no) Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
HUP0203321A2 (hu) (6-Metoxi-2-naftil)-ecetsav prodrug készítmények gyulladás kezelésére